How do endogenous oestrogens affect breast cancer?

European Journal of Cancer

Volumn 38, Issue SUPPL. 6, 2002, Pages

  Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AGE; ARTICLE; BONE DENSITY; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST TUMOR; CANCER RISK; CANCER SURGERY; ESTROGEN BLOOD LEVEL; FAT INTAKE; FOLLICULAR PHASE; GENDER; HEIGHT; HORMONE SUBSTITUTION; HUMAN; LUTEAL PHASE; MAMMOGRAPHY; MENSTRUAL CYCLE; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; WEIGHT; WEIGHT REDUCTION;

EID: 0036754194     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(02)00288-5     Document Type: Article

References (10)

1. Fisher B., Constantino J.P., Wickerham D.L.et al. Tamoxifen for prevention of breast cancer. report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst. 90:1998;1371-1388.
2. Cumming S.R., Eckert S., Krueger K.A.et al. The effect of raloxifene on risk of breast cancer in postmenopausal women. Results from MORE randomised trial. JAMA. 281:1999;2189-2197.
3. Fentiman I.S., Wang D.Y., Allen D.S.et al. Bone density of normal women in relation to endogenous and exogenous estrogens. Brit J Rheum. 33:1994;808-815.
4. Badwe R.A., Gregory W.M., Chaudary M.A.et al. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet. 337:1991;1261-1264.
5. Mohr P.E., Wang D.Y., Gregory W.M.et al. Serum progesterone and prognosis in operabel breast cancer. Br J Cancer. 73:1996;1552-1555.
6. Badwe R.A., Betteiheim R., Millis R.R.et al. Cyclical tumour variations in premenopausal women with early breast cancer. Eur J Cancer. 31A:1995;2181-2184.
7. Badwe R.A., Fentiman I.S., Millis R.R.et al. Body weight and vascular invasion in post-menopausal women with breast cancer. Br J Cancer. 75:1997;910-913.
8. Cooper L.S., Gillett C.E., Smith P.et al. Cell prolferation measured by MIBI and timing of surgery for breast cancer. Br J Cancer. 77:1998;1502-1507.
9. Cooper L.S., Gillet C.G., Patel N.K., Barnes D.M., Fentiman I.S. Survival of premenopausal breast cancer patients in relation to menstrual cycle timing of surgery and primary tumor ER/PR status. Cancer. 86:1999;2053-2058.
10. Wolfe J.N. Risk for breast cancer development determined by mammographic parenchymal patterns. Cancer. 37:1976;2486-2492.